CCC 2003

Return to Main Menu

Search 2003 Abstracts

CHS Poster Session - Clinical Hypertension

 

375 - RESISTANCE ARTERIES IN TYPE 2 DIABETIC PATIENTS UNDER ANTIHYPERTENSIVE TREATMENT SHOW MARKED REMODELING
D Endemann, Q Pu, C De Ciuceis, C Savoia, A Virdis, MF Neves, RM Touyz, EL Schiffrin
Montreal, Quebec

376 - INFLUENCE OF CIRCADIAN RHYTHMS, BODY POSTURE AND ANTIHYPERTENSIVE DRUGS ON THE ALDOSTERONE-TO-RENIN RATIO IN PATIENT WITH ESSENTIAL HYPERTENSION
M Lamarre-Cliché, J de Champlain, Y Lacourcière, L Poirier, P Larochelle
Montreal, Quebec

377 - ESTIMATE OF SILENT MYOCARDIAL ISCHAEMIA IN PATIENTS WITH ESSENTIAL AND SECONDARY ARTERIAL HYPERTENSION
K Sahakyan, SV Gurgenyan, SK Vatinyan, KR Sahakyan, IV Hovsepyan, KG Nikogosyan, LB Edilyan
Yerevan, Armenia

378 - ROLE OF THE THIAZIDE-SENSITIVE SODIUM CHLORIDE COTRANSPORTER GENE IN PRIMARY HYPERTENSION ASSOCIATED WITH HYPERCALCIURIA
A Keszei, A Mente, L Mirea, SB Bull, AG Logan
Toronto, Ontario

379 - AMLODIPINE VS LOSARTAN IN THE TREATMENT OF TYPE 2 DIABETIC PATIENTS WITH AMBULATORY HYPERTENSION AND NORMOALBUMINURIA OR MICROALBUMINURIA: A 3-YEAR ANALYSIS
L Poirier, Y Lacourcière
Quebec, Quebec

380 - CARDIOVASCULAR SAFETY OF LEVITRA™ (VARDENAFIL) IN PATIENTS RECEIVING ANTIHYPERTENSIVE MEDICATIONS: ANALYSIS OF PHASE III CLINICAL TRIALS
M Seger, J Zadra, JF Yale
Toronto, Ontario

381 - IMPROVING CARE AND QUALITY OF LIFE FOR PEOPLE WITH CHRONIC ILLNESS
S Tobe, G Pylypchuk, J Wentworth, S Porter, J Basiuk, N Perkins, C Tan, B Bauer
North Battleford, Saskatchewan

382 - ELEVATED PLASMA COAGULATION FXIIA LEVELS AND HIGH ‘NEW PRESSOR PROTEIN’ (NPP) ACTIVITY IN PEDIATRIC HEMODIALYSIS PATIENTS WITH UNEXPLAINED RENOPRIVAL HYPERTENSION
PC Papageorgiou, RJ Pearl, M Goldman,AA Amfilochiadis, R Rojkjaer, DF Geary, DH Osmond
Toronto, Ontario

383 - CORRELATION BETWEEN BLOOD PRESSURE AND INSULIN RESISTANCE
R Lewanczuk, B Paty, E Toth
Edmonton, Alberta

384 - ANTIHYPERTENSIVE EFFECTS OF TWO FIXED-DOSE COMBINATIONS OF LOSARTAN AND HYDROCHLOROTHIAZIDE VERSUS HYDROCHLOROTHIAZIDE MONOTHERAPY IN SUBJECTS WITH AMBULATORY SYSTOLIC HYPERTENSION
L Poirier, Y Lacourcière
Quebec, Quebec

385 - THE CARDIAC ARRHYTHMIAS IN ESSENTIAL HYPERTENSIVE PATIENTS WITH DIFFERENT TYPES OF THE LEFT VENTRICULAR HYPERTROPHY
SK Vatinyan, KR Sahakyan
Yerevan, Armenia

386 - ADVERSE CARDIOVASCULAR RISK PROFILE IN MIDDLE AGE WOMEN WITH A PAST HISTORY OF GESTATIONAL HYPERTENSION
J Girouard, Y Giguère, AA Kharfi, J-C Forest
Quebec, Quebec

387 - EFFECTS OF TRIMETAZIDINE ON TARGET ORGAN DAMAGE IN HYPERTENSIVE DIABETIC PATIENTS
KR Sahakyan, RP Sahakyan, SK Vatinyan, DN Aslanyan, ES Mikaelyan, MF Drampyan
Yerevan, Armenia

388 - THE EFFECT OF ANGIOTENSIN RECEPTOR BLOCKER EPROSARTAN MESYLATE ON PULSE PRESSURE IN THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION
RJ Shanlin Reiz, I Teitelbaum, M Chilvers
Toronto, Ontario

389 - EFFECT OF ADENOSINE BLOCKADE WITH CAFFEINE ON POST-EXERCISE HYPOTENSION IN HEALTHY SUBJECTS
CF Notarius, B Morris, JS Floras
Toronto, Ontario